Nuveen Asset Management’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.08M | Hold |
80,160
| – | – | ﹤0.01% | 2367 |
|
|
2024
Q3 | $2.01M | Hold |
80,160
| – | – | ﹤0.01% | 2407 |
|
|
2024
Q2 | $1.72M | Hold |
80,160
| – | – | ﹤0.01% | 2463 |
|
|
2024
Q1 | $1.49M | Hold |
80,160
| – | – | ﹤0.01% | 2526 |
|
|
2023
Q4 | $1.3M | Buy |
80,160
+602
| +0.8% | +$9.78K | ﹤0.01% | 2608 |
|
|
2023
Q3 | $1.1M | Sell |
79,558
-708
| -0.9% | -$9.78K | ﹤0.01% | 2534 |
|
|
2023
Q2 | $1.77M | Buy |
80,266
+4,445
| +6% | +$98.2K | ﹤0.01% | 2399 |
|
|
2023
Q1 | $1.65M | Sell |
75,821
-13,767
| -15% | -$299K | ﹤0.01% | 2417 |
|
|
2022
Q4 | $1.63M | Sell |
89,588
-14,293
| -14% | -$260K | ﹤0.01% | 2476 |
|
|
2022
Q3 | $2.36M | Sell |
103,881
-3,859
| -4% | -$87.8K | ﹤0.01% | 2316 |
|
|
2022
Q2 | $1.49M | Sell |
107,740
-349,458
| -76% | -$4.82M | ﹤0.01% | 2597 |
|
|
2022
Q1 | $10.5M | Buy |
457,198
+79,434
| +21% | +$1.82M | ﹤0.01% | 1614 |
|
|
2021
Q4 | $14.1M | Buy |
377,764
+77,364
| +26% | +$2.88M | ﹤0.01% | 1465 |
|
|
2021
Q3 | $12.7M | Sell |
300,400
-84,130
| -22% | -$3.56M | ﹤0.01% | 1609 |
|
|
2021
Q2 | $17.1M | Buy |
384,530
+201,711
| +110% | +$8.98M | 0.01% | 1490 |
|
|
2021
Q1 | $6.58M | Buy |
182,819
+107,252
| +142% | +$3.86M | ﹤0.01% | 2025 |
|
|
2020
Q4 | $3.01M | Buy |
75,567
+14,643
| +24% | +$584K | ﹤0.01% | 2305 |
|
|
2020
Q3 | $1.76M | Buy |
60,924
+39,964
| +191% | +$1.16M | ﹤0.01% | 2445 |
|
|
2020
Q2 | $343K | Buy |
+20,960
| New | +$343K | ﹤0.01% | 3014 |
|